Stockscreener 앱 받기
6.675
2.28%
-0.125
전일 마감가:
$6.80
열려 있는:
$6.8
하루 거래량:
123.59K
Relative Volume:
0.07
시가총액:
$621.07M
수익:
$823.60M
순이익/손실:
$-116.00M
주가수익비율:
-5.1346
EPS:
-1.3
순현금흐름:
$-107.30M
1주 성능:
+6.83%
1개월 성능:
+66.96%
6개월 성능:
-36.23%
1년 성능:
-73.80%
1일 변동 폭
$6.645
$6.80
1주일 범위
$6.21
$7.05
52주 변동 폭
$3.76
$29.30
Myriad Genetics Inc Stock (MYGN) Company Profile
명칭
Myriad Genetics Inc
전화
801-584-3600
주소
322 NORTH 2200 WEST, SALT LAKE CITY, UT
MYGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYGN
Myriad Genetics Inc
|
6.675 | 642.01M | 823.60M | -116.00M | -107.30M | -1.30 |
|
TMO
Thermo Fisher Scientific Inc
|
479.10 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
195.20 | 145.92B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
631.17 | 51.16B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.68 | 35.50B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.00 | 31.24B | 15.70B | 1.24B | 2.01B | 6.91 |
Myriad Genetics Inc Stock (MYGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-21 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-05-08 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2025-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2025-03-12 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-02-12 | 개시 | Craig Hallum | Buy |
| 2024-12-10 | 개시 | UBS | Neutral |
| 2024-12-09 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-09-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-27 | 개시 | Scotiabank | Sector Outperform |
| 2024-06-03 | 재개 | Jefferies | Underperform |
| 2024-05-08 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2023-12-21 | 재개 | Piper Sandler | Neutral |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-07-05 | 재개 | JP Morgan | Underweight |
| 2023-05-23 | 업그레이드 | Goldman | Sell → Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-10-06 | 개시 | Stephens | Equal-Weight |
| 2021-10-15 | 재개 | Cowen | Market Perform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-06-03 | 개시 | Goldman | Sell |
| 2019-09-26 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-08-14 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2019-08-02 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-08-01 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-07-29 | 다운그레이드 | Needham | Strong Buy → Hold |
| 2019-07-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2019-03-12 | 재확인 | Needham | Strong Buy |
| 2019-01-03 | 개시 | Needham | Strong Buy |
| 2018-11-30 | 업그레이드 | Goldman | Sell → Neutral |
| 2018-10-10 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-07-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-03-21 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2018-01-29 | 개시 | Goldman | Sell |
| 2018-01-22 | 재확인 | Barclays | Equal Weight |
| 2018-01-05 | 개시 | BTIG Research | Buy |
| 2017-10-02 | 재개 | Leerink Partners | Mkt Perform |
| 2017-08-09 | 재확인 | Barclays | Equal Weight |
| 2017-02-08 | 업그레이드 | Ladenburg Thalmann | Sell → Neutral |
| 2017-01-18 | 개시 | Deutsche Bank | Sell |
| 2016-10-10 | 다운그레이드 | Ladenburg Thalmann | Neutral → Sell |
모두보기
Myriad Genetics Inc 주식(MYGN)의 최신 뉴스
What analysts say about Myriad Genetics Inc. stockTrade Performance Summary & Daily Momentum Trading Reports - khodrobank.com
New meta-analysis demonstrates that access to the GeneSight test can significantly improve response and remission rates for patients with depression - MarketScreener
Myriad Genetics Announces Meta-Analysis Results Indicating GeneSight Test Enhances Remission and Response Rates in Major Depressive Disorder Patients - Quiver Quantitative
New Meta-Analysis Demonstrates that Access to the GeneSight - GlobeNewswire
41% Higher Depression Remission: Myriad Genetics' GeneSight Test Proves Superior in 3,500+ Patient Study - Stock Titan
Best data tools to analyze Myriad Genetics Inc. stockTrade Signal Summary & High Win Rate Trade Tips - Newser
Using portfolio simulators with Myriad Genetics Inc. includedQuarterly Trade Summary & High Win Rate Trade Tips - Newser
Analyzing recovery setups for Myriad Genetics Inc. investorsWeekly Profit Summary & Verified Swing Trading Watchlist - Newser
Combining price and volume data for Myriad Genetics Inc.Day Trade & Daily Profit Maximizing Tips - Newser
Will Myriad Genetics Inc. continue its uptrendJuly 2025 Closing Moves & Community Verified Trade Signals - Newser
Is Myriad Genetics Inc. showing signs of accumulationWeekly Profit Report & Consistent Return Strategy Ideas - Newser
Is Myriad Genetics Inc. stock entering bullish territoryWeekly Trade Recap & Real-Time Stock Movement Alerts - Newser
How to integrate Myriad Genetics Inc. into portfolio analysis toolsWeekly Investment Recap & Risk Controlled Daily Trade Plans - Newser
Relative strength of Myriad Genetics Inc. in sector analysisTrade Risk Summary & Short-Term High Return Ideas - Newser
Momentum divergence signals in Myriad Genetics Inc. chartEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Combining machine learning predictions for Myriad Genetics Inc.2025 Top Decliners & Community Verified Trade Alerts - Newser
Analyzing Myriad Genetics Inc. with multi timeframe charts2025 Year in Review & Growth Oriented Trade Recommendations - Newser
Myriad Genetics Inc. stock prediction for this weekJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Real time alert setup for Myriad Genetics Inc. performanceQuarterly Profit Review & Consistent Return Strategy Ideas - Newser
Can Myriad Genetics Inc. lead its sector in growthJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - khodrobank.com
Can Myriad Genetics Inc. outperform in the next rallyJuly 2025 Macro Moves & Fast Gaining Stock Strategy Reports - khodrobank.com
What chart patterns are forming on Myriad Genetics Inc.July 2025 Technicals & Weekly Market Pulse Alerts - khodrobank.com
Myriad Genetics Inc. stock trend forecastShort Setup & Daily Volume Surge Trade Alerts - Newser
How moving averages guide Myriad Genetics Inc. tradingWeekly Gains Summary & AI Forecast for Swing Trade Picks - Newser
Liquid Biopsy Market Trends and Industry Forecast to 2030 - GlobeNewswire
Liquid Biopsy Market Trends and Industry Forecast to 2030 Featuring Strategic Analysis of Natera, Guardant Health, Myriad Genetics, Illumina, and Roche Among Others - Yahoo Finance
Will Myriad Genetics Inc. see short term momentumOptions Play & Weekly Breakout Watchlists - Newser
Can volume confirm reversal in Myriad Genetics Inc.2025 Technical Patterns & Smart Investment Allocation Tips - Newser
What recovery options are there for Myriad Genetics Inc.Weekly Trade Summary & Weekly Stock Performance Updates - Newser
How does Myriad Genetics Inc. compare to its peersJuly 2025 Big Picture & Detailed Earnings Play Strategies - khodrobank.com
Predicting Myriad Genetics Inc. trend using moving averages2025 Dividend Review & Consistent Return Strategy Ideas - Newser
How to use Fibonacci retracement on Myriad Genetics Inc.2025 Market Trends & Weekly Market Pulse Updates - Newser
What Fibonacci levels say about Myriad Genetics Inc. rebound2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
Can Myriad Genetics Inc. recover in the next quarter2025 Trading Recap & AI Driven Price Predictions - Newser
Custom strategy builders for tracking Myriad Genetics Inc.Dollar Strength & High Yield Equity Trading Tips - Newser
Using AI based signals to follow Myriad Genetics Inc.July 2025 Summary & Comprehensive Market Scan Reports - Newser
Myriad Genetics Inc (MYGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.53%
0.09%
자본화:
|
볼륨(24시간):